Cargando…

Analysis of SOX2-Regulated Transcriptome in Glioma Stem Cells

INTRODUCTION: Glioblastoma is the most malignant brain tumor in adults and is associated with poor survival despite multimodal treatments. Glioma stem-like cells (GSCs) are cells functionally defined by their self-renewal potential and the ability to reconstitute the original tumor upon orthotopic i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Acanda de la Rocha, Arlet M., López-Bertoni, Hernando, Guruceaga, Elizabeth, González-Huarriz, Marisol, Martínez-Vélez, Naiara, Xipell, Enric, Fueyo, Juan, Gomez-Manzano, Candelaria, Alonso, Marta M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036841/ https://www.ncbi.nlm.nih.gov/pubmed/27669421 http://dx.doi.org/10.1371/journal.pone.0163155

Ejemplares similares

miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs
por: de la Rocha, Arlet María Acanda, et al.
Publicado: (2020)

Erratum: miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs
por: de la Rocha, Arlet María Acanda, et al.
Publicado: (2021)

Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
por: Vera, Beatriz, et al.
Publicado: (2016)

Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
por: Vera, Beatriz, et al.
Publicado: (2016)

Salinomycin induced ROS results in abortive autophagy and leads to regulated necrosis in glioblastoma
por: Xipell, Enric, et al.
Publicado: (2016)

Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models
por: Martinez-Velez, Naiara, et al.
Publicado: (2019)

Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas
por: Laspidea, Virginia, et al.
Publicado: (2022)

Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory
por: Martinez-Velez, Naiara, et al.
Publicado: (2022)

DNX-2401, an Oncolytic Virus, for the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Gliomas: A Case Report
por: Tejada, Sonia, et al.
Publicado: (2018)

Oncolytic Viruses as Therapeutic Tools for Pediatric Brain Tumors
por: Varela-Guruceaga, Maider, et al.
Publicado: (2018)

Genetic and Epigenetic Modifications of Sox2 Contribute to the Invasive Phenotype of Malignant Gliomas
por: Alonso, Marta M., et al.
Publicado: (2011)

The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
por: Martínez-Vélez, Naiara, et al.
Publicado: (2019)

Development of a DIPG Orthotopic Model in Mice Using an Implantable Guide-Screw System
por: Marigil, Miguel, et al.
Publicado: (2017)

THER-02. EVALUATION OF THE ONCOLYTIC VIRUS DELTA24-RGD AS AN ANTI-TUMOR AGENT IN PRECLINICAL MODELS OF LOCALIZED AND DISSEMINATED AT/RT
por: Garcia-Moure, Marc, et al.
Publicado: (2020)

CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models
por: Puigdelloses, Montserrat, et al.
Publicado: (2021)

The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models
por: Garcia-Moure, Marc, et al.
Publicado: (2019)

Tie2/TEK Modulates the Interaction of Glioma and Brain Tumor Stem Cells with Endothelial Cells and Promotes an Invasive Phenotype
por: Liu, Dan, et al.
Publicado: (2010)

THER-01. AWAKING THE IMMUNE SYSTEM WITH AN IMMUNO-ONCOLYTIC VIRUS AS A THERAPEUTIC STRATEGY FOR DIPGs
por: Laspidea, Virginia, et al.
Publicado: (2020)

Potentiation of anti-glioma immunity induced by oncolytic adenovirus Delta-24-RGD through viral expression of immune co-stimulator OX40 ligand
por: Jiang, Hong, et al.
Publicado: (2015)

Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas
por: Cortes-Santiago, Nahir, et al.
Publicado: (2016)

EPCT-04. RESULTS OF A PHASE 1 STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 WITH RADIOTHERAPY FOR NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
por: Garcia-Moure, Marc, et al.
Publicado: (2021)

THER-09. ONCOLYTIC ADENOVIRUS, DNX-2401, FOR NAIVE DIFFUSE INTRINSIC PONTINE GLIOMAS: A PHASE I CLINICAL TRIAL
por: Iñigo-Marco, Ignacio, et al.
Publicado: (2020)

IMMU-18. Targeting Antigen Presenting Cells to improve virotherapy efficacy in Diffuse Midline Gliomas
por: Labiano, Sara, et al.
Publicado: (2022)

GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory
por: Rivera-Molina, Yisel, et al.
Publicado: (2019)

Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy
por: Shin, Dong Ho, et al.
Publicado: (2021)

Macrophage Ablation Reduces M2-Like Populations and Jeopardizes Tumor Growth in a MAFIA-Based Glioma Model()()
por: Gabrusiewicz, Konrad, et al.
Publicado: (2015)

Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes
por: Gabrusiewicz, Konrad, et al.
Publicado: (2014)

Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens
por: Klein, Sarah R., et al.
Publicado: (2016)

Local administration of IL-12 with an HC vector results in local and metastatic tumor control in pediatric osteosarcoma
por: Zalacain, Marta, et al.
Publicado: (2020)

Remission of liquid tumors and SARS-CoV-2 infection: A literature review
por: Shin, Dong Ho, et al.
Publicado: (2022)

IMMU-01. THE ONCOLYTIC VIRUS DELTA-24-RGD IN COMBINATION WITH AN AGONISTIC CD40 MAB INDUCES A DURABLE AND SYNERGISTIC ANTI-TUMOR IMMUNE EFFECT IN DIPG PRECLINICAL MODELS
por: Labiano, Sara, et al.
Publicado: (2021)

Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model
por: Jiang, Hong, et al.
Publicado: (2014)

DIPG-10. DELTA-24-RGDOX PROMOTES ANTITUMOR IMMUNE RESPONSE IN DMG MODELS
por: Laspidea, Virginia, et al.
Publicado: (2023)

IMMU-06. DELTA-24-RGD EXPRESSING POSITIVE IMMUNE MODULATORS SHOW ANTI-DIPG EFFECT AND INCREASE TUMOR IMMUNE INFILTRATION
por: Laspidea, Virginia, et al.
Publicado: (2021)

Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection
por: González-Morales, Andrea, et al.
Publicado: (2018)

The E1B19K Oncoprotein Complexes with Beclin 1 to Regulate Autophagy in Adenovirus-Infected Cells
por: Piya, Sujan, et al.
Publicado: (2011)

Endocytosis as a Biological Response in Receptor Pharmacology: Evaluation by Fluorescence Microscopy
por: Campa, Víctor M., et al.
Publicado: (2015)

Glioma SOX2 expression decreased after adjuvant therapy
por: Yu, Wei, et al.
Publicado: (2019)

HGG-15. THE IMIPRIDONE ONC201 IN COMBINATION WITH THE ONCOLYTIC ADENOVIRUS DELTA-24-RGD HAS A SYNERGISTIC EFFECT IN PRECLINICAL MODELS OF PHGGS AND DMGS
por: de la Nava, Daniel, et al.
Publicado: (2021)

mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
por: Garros-Regulez, Laura, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_60p4p5pb647h8fm6qd969rrcjs